EGFR and non-small cell lung carcinoma: To investigate the possible mechanisms underlying the primary resistance to EGFR-TKIs, we identified the aberrant alterations of 8 driver genes, and then analyzed the association between these genetic alterations and survival in a cohort of 416 consecutive NSCLC patients.